Skip to main content
ConductScienceScienceDex

Monte Meier Winslow

NIH Rank #6627
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10201426Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Genetics
  • ENGINEERING (ALL TYPES)

NIH Funding · FY2024

Linked Award Amount
$1.8M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#6,627
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Monte Meier Winslow. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Monte Meier Winslow as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA263715-04R01
    Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer
    Yale University
    $536.7K
    award amount
  • 5U01AG077922-04U01
    Dissecting the interplay between aging, genotype and the microenvironment in lung cancer
    Stanford University
    $457.1K
    award amount
  • 5R01CA230025-04R01
    Genetic dissection of oncogenic Kras signaling
    Stanford University
    $415.8K
    award amount
  • 5R61CA278398-02R61
    Program the Immune System against RAS-driven Cancer
    Stanford University
    $207.9K
    award amount
  • 3U01AG077922-04S1U01
    Genetic analysis of aging on immune responses to lung cancer
    Stanford University
    $156K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Monte Meier Winslow as a PI.

Stanford University
CA
$1.2M
4 grants
Yale University
CT
$536.7K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Stanford University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6627
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Monte Meier Winslow.

Dmitri Petrov
Stanford University
3
shared awards
Katerina Abigail Politi
Yale University
2
shared awards
Xiaojing J Gao
Stanford University
2
shared awards
Nathan Edward Reticker-flynn
Stanford University
1
shared award

Explore further

Find collaborators for Monte Meier Winslow

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →